News - Page 123 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

Post published:January 18, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Post published:January 18, 2022
Post category:Press Release

Read more about the article Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health Canada’s Special Access Program

Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health Canada’s Special Access Program

Post published:January 18, 2022
Post category:Press Release

Read more about the article MindMed Enrolls First Participant in a Study of its Session Monitoring System

MindMed Enrolls First Participant in a Study of its Session Monitoring System

Post published:January 18, 2022
Post category:Press Release

Read more about the article Psygen Receives Dealer’s Licence from Health Canada

Psygen Receives Dealer’s Licence from Health Canada

Post published:January 17, 2022
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: December 2021

Psychedelic Research Bulletin: December 2021

Post published:January 17, 2022
Post category:Psychedelics Research Review

Read more about the article Filament Health and Cybin Therapeutics Announce Licensing Agreement

Filament Health and Cybin Therapeutics Announce Licensing Agreement

Post published:January 17, 2022
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Post published:January 17, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule Psilocybin Emerges; We Review Psychedelic Research and Trials from 2021

Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule Psilocybin Emerges; We Review Psychedelic Research and Trials from 2021

Post published:January 14, 2022
Post category:Psychedelic Bulletin

Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product

Post published:January 14, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.